PBF
ABBV icon

Petix & Botte Financial’s AbbVie ABBV Stock Holding History

Petix & Botte Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
1,870
+935
+100% +$201K 0.09% 94
2026
Q1 		$407K Sell
935
-935
-50% -$207K 0.09% 95
2025
Q4 		$427K Hold
1,870
– – 0.1% 91
2025
Q3 		$433K Sell
1,870
-3,364
-64% -$685K 0.1% 90
2025
Q2 		$972K Sell
5,234
-3,384
-39% -$629K 0.24% 57
2025
Q1 		$1.81M Hold
8,618
– – 0.48% 40
2024
Q4 		$1.53M Hold
8,618
– – 0.4% 45
2024
Q3 		$1.7M Hold
8,618
– – 0.45% 36
2024
Q2 		$1.48M Buy
8,618
+4,309
+100% +$714K 0.42% 37
2024
Q1 		$785K Sell
4,309
-4,327
-50% -$746K 0.19% 75
2023
Q4 		$1.34M Buy
8,636
+18
+0.2% +$2.62K 0.39% 39
2023
Q3 		$1.28M Hold
8,618
– – 0.41% 39
2023
Q2 		$1.16M Buy
8,618
+4,309
+100% +$632K 0.36% 42
2023
Q1 		$687K Buy
+4,309
New +$659K 0.46% 41
2022
Q3 		$578K Buy
4,309
+414
+11% +$59.4K 0.44% 39
2022
Q2 		$597K Sell
3,895
-3,895
-50% -$595K 0.44% 40
2022
Q1 		$1.26M Buy
7,790
+3,895
+100% +$566K 0.39% 39
2021
Q4 		$527K Sell
3,895
-3,853
-50% -$455K 0.34% 47
2021
Q3 		$836K Buy
7,748
+3,874
+100% +$443K 0.28% 52
2021
Q2 		$436K Hold
3,874
– – 0.3% 56
2021
Q1 		$419K Hold
3,874
– – 0.31% 57
2020
Q4 		$415K Hold
3,874
– – 0.31% 56
2020
Q3 		$339K Sell
3,874
-3,874
-50% -$365K 0.27% 60
2020
Q2 		$381K Buy
7,748
+3,874
+100% +$341K 0.31% 54
2020
Q1 		$295K Buy
3,874
+200
+5% +$17K 0.29% 57
2019
Q4 		$325K Buy
+3,674
New +$305K 0.26% 63

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Petix & Botte Financial's ABBV Position: Q2 2026 in Review

Petix & Botte Financial increased its AbbVie (ABBV) stake by 100% in Q2 2026, buying an estimated $201K and bringing the position to 1,870 shares worth $471K. The position accounts for 0.09% of the portfolio, ranked #94.

Petix & Botte Financial first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.81M in Q1 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Petix & Botte Financial held 1,870 shares of AbbVie worth $471K as of Q2 2026.
  • Petix & Botte Financial bought 935 AbbVie shares in Q2 2026, an estimated $201K.
  • AbbVie made up 0.09% of Petix & Botte Financial's portfolio in Q2 2026, its #94 holding.
  • Petix & Botte Financial first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Petix & Botte Financial's AbbVie position peaked at $1.81M in Q1 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Petix & Botte Financial's 13F filing for Q2 2026, filed 4 Aug 2026.